Skip to content

Relay Therapeutics, Inc.

RLAY

CIK 0001812364

← back to feed
Revenue (TTM)
$11.36M
+53.4% YoY Q1 May 2026
Net Income (TTM)
−$294.88M
+18.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.71
+31.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-2,824.0%
Q1 May 2026
Net Margin
-2,596.7%
Q1 May 2026
Free Cash Flow (TTM)
−$248.65M
Q1 May 2026
Cash
$204.59M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
191.59M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings